Categories: News

Dr. Douglas C. Morrow, OD Provides Notification of Data Security Incident

AUBURN, Ind., Feb. 23, 2022 /PRNewswire/ — On May 16, 2021, Dr. Douglas C. Morrow, OD (“Dr. Morrow”) experienced a data security incident that prevented users from accessing systems and data. Upon discovering this incident, Dr. Morrow immediately launched an investigation and engaged a digital forensics firm to help determine what happened and what information may have been accessed. On October 29, 2021, the investigation determined that the attacker gained access to Dr. Morrow’s data and may have acquired protected health information. On December 8, 2021, Dr. Morrow identified individuals whose protected personal information may have been compromised. The types of information potentially accessed varied by individual, but may have included name, address, Social Security number, driver’s license, medical information, and health insurance information. The specific types of medical information and/or health insurance information that may have been accessed include Member/Medicaid ID numbers, treatment/diagnosis information, dates of service, provider name(s), patient account number(s), and medical record number(s).

Impacted individuals were notified beginning on February 23, 2022.  The notification included information about this incident and measures that can be taken to protect personal information and protected health information, including free identity monitoring and recovery services.  To enroll in these services, affected individuals must call the toll-free number: 1-833-676-2192.

About Dr. Douglas C. Morrow, OD:

Dr. Morrow is an Optometric Doctor serving the Auburn, Indiana area for the past 28 years.

 

View original content:https://www.prnewswire.com/news-releases/dr-douglas-c-morrow-od-provides-notification-of-data-security-incident-301489094.html

SOURCE Dr. Douglas C. Morrow, OD

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

14 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

14 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago